Zhejiang Medicine Co (SHSE:600216) EPS (Basic) : ¥1.02 (TTM As of Sep. 2024)

View and export this data going back to 1999. Start your Free Trial

What is Zhejiang Medicine Co EPS (Basic)?

Zhejiang Medicine Co's basic earnings per share (Basic EPS) for the three months ended in Sep. 2024 was ¥0.55. Its basic earnings per share (Basic EPS) for the trailing twelve months (TTM) ended in Sep. 2024 was ¥1.02.

Zhejiang Medicine Co's EPS (Diluted) for the three months ended in Sep. 2024 was ¥0.55. Its EPS (Diluted) for the trailing twelve months (TTM) ended in Sep. 2024 was ¥1.02.

Zhejiang Medicine Co's EPS without NRI for the three months ended in Sep. 2024 was ¥0.57. Its EPS without NRIearnings per share without non-recurring items for the trailing twelve months (TTM) ended in Sep. 2024 was 0.89.

During the past 12 months, Zhejiang Medicine Co's average EPS without NRIGrowth Rate was 135.50% per year. During the past 3 years, the average EPS without NRI Growth Rate was -36.00% per year. During the past 5 years, the average EPS without NRI Growth Rate was -4.20% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EPS without NRI Growth Rate using EPS without NRI data.

During the past 13 years, Zhejiang Medicine Co's highest 3-Year average EPS without NRI Growth Rate was 169.60% per year. The lowest was -44.00% per year. And the median was 1.40% per year.

Zhejiang Medicine Co EPS (Basic) Historical Data

The historical data trend for Zhejiang Medicine Co's EPS (Basic) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Zhejiang Medicine Co EPS (Basic) Chart

Zhejiang Medicine Co Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

EPS (Basic)

Get a 7-Day Free Trial

0.36

0.75

1.09

0.56

0.45

Zhejiang Medicine Co Quarterly Data
	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24
EPS (Basic)	Get a 7-Day Free Trial															0.03	0.14	0.11	0.22	0.55

Zhejiang Medicine Co EPS (Basic) Calculation

EPS (Basic) is a rough measurement of the amount of a company's profit that can be allocated to one share of its stock. Basic earnings per share (EPS) do not factor in the dilutive effects on convertible securities.

Zhejiang Medicine Co's Basic EPS for the fiscal year that ended in Dec. 2023 is calculated as

Basic EPS (A: Dec. 2023 )	=	(Net Income	-	Preferred Dividends)	/	Shares Outstanding (Basic Average)
	=	(429.64	-	0)	/	954.755
	=	0.45

Zhejiang Medicine Co's Basic EPS for the quarter that ended in Sep. 2024 is calculated as

Basic EPS (Q: Sep. 2024 )	=	(Net Income	-	Preferred Dividends)	/	Shares Outstanding (Basic Average)
	=	(534.32	-	0)	/	985.437
	=	0.54

EPS (Basic) for the trailing twelve months (TTM) ended in Sep. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥1.02

Zhejiang Medicine Co (SHSE:600216) EPS (Basic) Explanation

EPS is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists EPS without NRI, which better reflects the company's underlying performance.

Be Aware

Compared with Earnings per share, a company's cash flow is better indicator of the company's earnings power.

If a company's earnings per share is less than cash flow per share over long term, investors need to be cautious and find out why.

Zhejiang Medicine Co EPS (Basic) Related Terms

Thank you for viewing the detailed overview of Zhejiang Medicine Co's EPS (Basic) provided by GuruFocus.com. Please click on the following links to see related term pages.

Zhejiang Medicine Co Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Zhejiang Medicine Co Ltd (SHSE:600216) » Definitions » EPS (Basic)

Traded in Other Exchanges

N/A

Address

Comprehensive Building, No. 398 Mahuan Road, 3rd Floor, Building A, Binhai New City, Shaoxing, CHN, 312366

Website

http://www.china-zmc.com

Zhejiang Medicine Co Ltd is a china-based pharmaceutical company. The company manufactures fat-soluble vitamins, vitamins, quinolones, and antibiotic-resistant antibiotics, vitamin E, natural vitamin E, beta-carotene, cantharidin, vancomycin hydrochloride, and teicoplanin.

Executives

Zhu Jin Lin	senior management
Chu Zhen Hua	Director
Liang Bi Rong	Director
Yu Yu Qing	Director
Ping Jian Hong	senior management
An Yong Bin	senior management
Wang Xiao Ping	senior management
Liang Li Ping	senior management
Li Qi Rong	senior management
Zhu Shao Ming	Supervisors
Wang Hong Wei	senior management
Zhang Ding Feng	senior management
Ma Wen Xin	Director
Zhao Jun Xing	senior management
Lv Yong Hui	Director

Zhejiang Medicine Co Headlines

No Headlines